Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Mastectomy | Research

Predictors of surgery choices in women with early-stage breast cancer in China: a retrospective study

Authors: Sijia Huang, Qingmo Yang, Xujuan Zheng, Ka Ming Chow, Junhua Wu, Jiemin Zhu

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

The breast-conserving surgery and reconstruction rate in China is relatively low when compared with those in Western countries. Moreover, predictors of surgical choices for women with breast cancer in China have not yet been explored. This study aims to explore differences in the surgical choices of women with different demographic and clinical characteristics and the predictors that influence surgical choices of women with early-stage breast cancer.

Methods

This retrospective study included women with early-stage (0-II) breast cancer who underwent surgeries at one of two Xiamen University-affiliated hospitals between 2009 and 2017. Using medical records, eleven variables were collected: the woman's age, year of diagnosis, hospital, marital status, payment method, cancer stage, presence of positive axillary lymph node, histology, neoadjuvant chemotherapy, radiotherapy, and the type(s) of surgery they chose. Binary logistic regression was used to analyse predictors of surgical choice.

Results

A total of 1,787 cases were included in this study. Of the total number of women with breast cancer, 61.3% underwent mastectomy without breast reconstruction, 26.4% underwent mastectomy with breast reconstruction, and the remaining 12.2% chose breast-conserving surgery. Women with different demographic and clinical characteristics underwent different types of surgery. Cancer stage, neoadjuvant chemotherapy, radiotherapy, and the choice of hospital were found to be predictors of breast-conserving surgery. Meanwhile, age, year of diagnosis, payment method, neoadjuvant chemotherapy, and the choice of hospital were found to be predictors of reconstruction after mastectomy in women with early-stage breast cancer.

Conclusions

In China, surgical choices for women with breast cancer have diversified. Healthcare workers should understand the surgical preferences of women of different ages. For early detection of breast cancer, knowledge of breast self-examination and breast cancer screening should be provided. Adequate information about the safety of reconstruction and advocacy for medical insurance coverage of reconstruction should be offer. Breast surgeons need specialised training and standardising protocols towards different types of breast surgery. These actions will help women make better, well-informed decisions about their breast surgeries.
Literature
1.
go back to reference Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–89.CrossRef Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–89.CrossRef
3.
go back to reference Li J, Zhang BN, Fan JH, Pang Y, Zhang P, Wang SL, et al. A nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer. 2011;11(1):364.CrossRef Li J, Zhang BN, Fan JH, Pang Y, Zhang P, Wang SL, et al. A nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer. 2011;11(1):364.CrossRef
4.
go back to reference Litière S, Werutsk G, Fentiman IS, Em Rutgers MR, Christiaens EV Limbergen, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412–9.CrossRef Litière S, Werutsk G, Fentiman IS, Em Rutgers MR, Christiaens EV Limbergen, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412–9.CrossRef
5.
go back to reference Yang B, Ren G, Song E, Pan D, Zhang J, Wang Y, et al. Current status and factors influencing surgical options for breast cancer in china: a nationwide cross-sectional survey of 110 hospitals. Oncologist. 2020;25(10):e1473–80.CrossRef Yang B, Ren G, Song E, Pan D, Zhang J, Wang Y, et al. Current status and factors influencing surgical options for breast cancer in china: a nationwide cross-sectional survey of 110 hospitals. Oncologist. 2020;25(10):e1473–80.CrossRef
6.
go back to reference Quyen D, Mei-Chin H, Lyons JM, Wu XC. 10-Year survival after breast-conserving surgery compared with mastectomy in Louisiana women with early-stage breast cancer: a population-based study. J Am Coll Surg. 2021;232(4):607–21.CrossRef Quyen D, Mei-Chin H, Lyons JM, Wu XC. 10-Year survival after breast-conserving surgery compared with mastectomy in Louisiana women with early-stage breast cancer: a population-based study. J Am Coll Surg. 2021;232(4):607–21.CrossRef
7.
go back to reference Kummerow K, Liping D, Penson D, Shyr Y, Hooks M. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg. 2015;150(1):9–16.CrossRef Kummerow K, Liping D, Penson D, Shyr Y, Hooks M. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg. 2015;150(1):9–16.CrossRef
8.
go back to reference Kang SY, Kim YS, Kim Z, Kim HY, Kim HJ, Park S, et al. Breast cancer statistics in Korea in 2017: data from a breast cancer registry. J Breast Cancer. 2020;23(2):115–28.CrossRef Kang SY, Kim YS, Kim Z, Kim HY, Kim HJ, Park S, et al. Breast cancer statistics in Korea in 2017: data from a breast cancer registry. J Breast Cancer. 2020;23(2):115–28.CrossRef
9.
go back to reference Jeevan R. Reconstructive utilisation and outcomes following mastectomy surgery in women with breast cancer treated in England. Ann R Coll Surg Engl. 2020;102(2):1–5.CrossRef Jeevan R. Reconstructive utilisation and outcomes following mastectomy surgery in women with breast cancer treated in England. Ann R Coll Surg Engl. 2020;102(2):1–5.CrossRef
11.
go back to reference Hieken TJ, Boughey JC. Contralateral prophylactic mastectomy and its impact on quality of life. Gland Surg. 2016;5(4):439–43.CrossRef Hieken TJ, Boughey JC. Contralateral prophylactic mastectomy and its impact on quality of life. Gland Surg. 2016;5(4):439–43.CrossRef
12.
go back to reference Zahedi S, Colvill K, Lopez M, Phillips LG. Implications of demographics and socioeconomic factors in breast cancer reconstruction. Ann Plast Surg. 2019;83(4):388–91.CrossRef Zahedi S, Colvill K, Lopez M, Phillips LG. Implications of demographics and socioeconomic factors in breast cancer reconstruction. Ann Plast Surg. 2019;83(4):388–91.CrossRef
13.
go back to reference Flanagan MR, Zabor EC, Romanoff A, Fuzesi S, Gemignani. A comparison of patient-reported outcomes after breast-conserving surgery and mastectomy with implant breast reconstruction. Ann Surg Oncol. 2019;26(10):3133–40. Flanagan MR, Zabor EC, Romanoff A, Fuzesi S, Gemignani. A comparison of patient-reported outcomes after breast-conserving surgery and mastectomy with implant breast reconstruction. Ann Surg Oncol. 2019;26(10):3133–40.
14.
go back to reference Park J, Haque FM, Chedjou AL, Miller MJ, Sutradhar A. Breast asymmetry evaluation using objective measures after breast cancer surgery. J Biomed Sci Eng. 2021;14(1):1–10.CrossRef Park J, Haque FM, Chedjou AL, Miller MJ, Sutradhar A. Breast asymmetry evaluation using objective measures after breast cancer surgery. J Biomed Sci Eng. 2021;14(1):1–10.CrossRef
15.
go back to reference Chen R, You S, Yin Z, Zu Q, Jiang C, Li S, et al. Non-doctoral factors influencing the surgical choice of Chinese patients with breast cancer who were eligible for breast-conserving surgery. World J Surg Oncol. 2019;17(1):189.CrossRef Chen R, You S, Yin Z, Zu Q, Jiang C, Li S, et al. Non-doctoral factors influencing the surgical choice of Chinese patients with breast cancer who were eligible for breast-conserving surgery. World J Surg Oncol. 2019;17(1):189.CrossRef
16.
go back to reference Huang NS, Liu MY, Chen JJ, Yang BL, Xue JY, Quan CL, et al. Surgical management of breast cancer in China: a 15-year single-center retrospective study of 18,502 patients. Medicine (Baltimore). 2016;95(45): e4201.CrossRef Huang NS, Liu MY, Chen JJ, Yang BL, Xue JY, Quan CL, et al. Surgical management of breast cancer in China: a 15-year single-center retrospective study of 18,502 patients. Medicine (Baltimore). 2016;95(45): e4201.CrossRef
17.
go back to reference Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279–89.CrossRef Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279–89.CrossRef
18.
go back to reference Ng SK, Hare RM, Kuang RJ, Smith KM, Brown BJ, Hunter-Smith DJ. Breast reconstruction post mastectomy: patient satisfaction and decision making. Ann Plast Surg. 2016;76(6):640–4.CrossRef Ng SK, Hare RM, Kuang RJ, Smith KM, Brown BJ, Hunter-Smith DJ. Breast reconstruction post mastectomy: patient satisfaction and decision making. Ann Plast Surg. 2016;76(6):640–4.CrossRef
19.
go back to reference Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.CrossRef Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.CrossRef
20.
go back to reference Zhang L, Gao JD, Lin DC, Xie L, Wang TY, Zou LQ. Personal factors influencing breast cancer patients’ perception of breast conservation surgery in West China. Ann Transl Med. 2019;7(14):313.CrossRef Zhang L, Gao JD, Lin DC, Xie L, Wang TY, Zou LQ. Personal factors influencing breast cancer patients’ perception of breast conservation surgery in West China. Ann Transl Med. 2019;7(14):313.CrossRef
21.
go back to reference Teo I, Reece GP, Christie IC, Guindani M, Markey MK, Heinberg LJ, et al. Body image and quality of life of breast cancer patients: influence of timing and stage of breast reconstruction. Psychooncology. 2016;25(9):1106–12.CrossRef Teo I, Reece GP, Christie IC, Guindani M, Markey MK, Heinberg LJ, et al. Body image and quality of life of breast cancer patients: influence of timing and stage of breast reconstruction. Psychooncology. 2016;25(9):1106–12.CrossRef
22.
go back to reference van der Meer DJ, Kramer I, van Maaren MC, van Diest PJ, Linn SC, Maduro JH, et al. Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017. Int J Cancer. 2021;148(9):2289–303.CrossRef van der Meer DJ, Kramer I, van Maaren MC, van Diest PJ, Linn SC, Maduro JH, et al. Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017. Int J Cancer. 2021;148(9):2289–303.CrossRef
23.
go back to reference Obeidat R, Masri M, Marzouq M. Factors affecting Jordanian women’s surgical treatment decisions for early-stage breast cancer. Asia Pac J Oncol Nurs. 2021;8(6):711–9.CrossRef Obeidat R, Masri M, Marzouq M. Factors affecting Jordanian women’s surgical treatment decisions for early-stage breast cancer. Asia Pac J Oncol Nurs. 2021;8(6):711–9.CrossRef
24.
go back to reference Zhang BL, Sivasubramaniam PG, Zheng Q, Wang J, Zhang B, Gao JD, et al. Trends in radical surgical treatment methods for breast malignancies in China: a multicenter 10-year retrospective study. Oncologist. 2015;20(9):1036–43.CrossRef Zhang BL, Sivasubramaniam PG, Zheng Q, Wang J, Zhang B, Gao JD, et al. Trends in radical surgical treatment methods for breast malignancies in China: a multicenter 10-year retrospective study. Oncologist. 2015;20(9):1036–43.CrossRef
25.
go back to reference Choi E, Jun JK, Suh M, Jung KW, Park B, Lee K, et al. Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality. NPJ Breast Cancer. 2021;7(1):83.CrossRef Choi E, Jun JK, Suh M, Jung KW, Park B, Lee K, et al. Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality. NPJ Breast Cancer. 2021;7(1):83.CrossRef
26.
go back to reference van der Waal D, Ripping TM, Verbeek A, Broeders M. Breast cancer screening effect across breast density strata: a case-control study. Int J Cancer. 2017;140(1):41–9.CrossRef van der Waal D, Ripping TM, Verbeek A, Broeders M. Breast cancer screening effect across breast density strata: a case-control study. Int J Cancer. 2017;140(1):41–9.CrossRef
27.
go back to reference Wang B, He M, Wang LM, Engelgau M, Zhao WH, Wang L. Breast cancer screening among adult women in China, 2010. Prev Chronic Dis. 2013;10:E183.CrossRef Wang B, He M, Wang LM, Engelgau M, Zhao WH, Wang L. Breast cancer screening among adult women in China, 2010. Prev Chronic Dis. 2013;10:E183.CrossRef
28.
go back to reference Greenup RA, Rushing C, Fish L, Campbell BM, Tolnitch L, Hyslop T, et al. Financial costs and burden related to decisions for breast cancer surgery. J Oncol Pract. 2019;15(8):e666-w676.CrossRef Greenup RA, Rushing C, Fish L, Campbell BM, Tolnitch L, Hyslop T, et al. Financial costs and burden related to decisions for breast cancer surgery. J Oncol Pract. 2019;15(8):e666-w676.CrossRef
29.
go back to reference Kumar NG, Berlin NL, Hawley ST, Jagsi R, Momoh AO. Financial toxicity in breast reconstruction: a national survey of women who have undergone breast reconstruction after mastectomy. Ann Surg Oncol. 2021;29(1):535–44. Kumar NG, Berlin NL, Hawley ST, Jagsi R, Momoh AO. Financial toxicity in breast reconstruction: a national survey of women who have undergone breast reconstruction after mastectomy. Ann Surg Oncol. 2021;29(1):535–44.
30.
go back to reference Asaad M, Bailey C, Boukovalas S, Liu J, Clemens MW, Selber J, et al. Self-reported risk factors for financial distress and attitudes regarding cost discussions in cancer care: a single-institution cross-sectional pilot study of breast reconstruction recipients. Plast Reconstr Surg. 2021;147(4):587e–e595.CrossRef Asaad M, Bailey C, Boukovalas S, Liu J, Clemens MW, Selber J, et al. Self-reported risk factors for financial distress and attitudes regarding cost discussions in cancer care: a single-institution cross-sectional pilot study of breast reconstruction recipients. Plast Reconstr Surg. 2021;147(4):587e–e595.CrossRef
31.
go back to reference Golshan M, Loibl S, Wong SM, Huober JB, O’Shaughnessy J, Rugo Hs, et al. Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results from the BrighTNess Randomized Clinical Trial. JAMA Surg. 2020;155(3):e195410.CrossRef Golshan M, Loibl S, Wong SM, Huober JB, O’Shaughnessy J, Rugo Hs, et al. Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results from the BrighTNess Randomized Clinical Trial. JAMA Surg. 2020;155(3):e195410.CrossRef
32.
go back to reference Fatayer H, O’Connell RL, Bannon F, Coles CE, Copson E, Cutress RI, et al. Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study. Br J Surg. 2022;109(9):800–3. Fatayer H, O’Connell RL, Bannon F, Coles CE, Copson E, Cutress RI, et al. Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study. Br J Surg. 2022;109(9):800–3.
33.
go back to reference Asselain B, Barlow W, Bartlett J, Bergh J, Bergsten-Nordstrom E, Bliss J, et al. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2018;19(1):27–39.CrossRef Asselain B, Barlow W, Bartlett J, Bergh J, Bergsten-Nordstrom E, Bliss J, et al. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2018;19(1):27–39.CrossRef
34.
go back to reference Gradishar WJ, Anderson BO, Abraham J, Aft R, Kumar R. Breast cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw: JNCCN. 2020;18(4):452–78.CrossRef Gradishar WJ, Anderson BO, Abraham J, Aft R, Kumar R. Breast cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw: JNCCN. 2020;18(4):452–78.CrossRef
35.
go back to reference Fan L, Strasser-Weippl K, Li J-J, St Louis J, Finkelstein DM, Yu K-D, et al. Breast cancer in China. Lancet Oncol. 2014;15:e279–89.CrossRef Fan L, Strasser-Weippl K, Li J-J, St Louis J, Finkelstein DM, Yu K-D, et al. Breast cancer in China. Lancet Oncol. 2014;15:e279–89.CrossRef
36.
go back to reference Müller C, Juhasz-Bss I, Schmidt G, Jungmann P, Juhasz-Bss S. Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients. Arch Gynecol Obstet. 2020;301(4):1055–9.CrossRef Müller C, Juhasz-Bss I, Schmidt G, Jungmann P, Juhasz-Bss S. Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients. Arch Gynecol Obstet. 2020;301(4):1055–9.CrossRef
37.
go back to reference Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330–9.CrossRef Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330–9.CrossRef
38.
go back to reference Carey LA, Claire DE, Lynda S, Lisa G, Moore DT, Frances C, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res: an official journal of the American Association for Cancer Research. 2017;13(8):2329–34.CrossRef Carey LA, Claire DE, Lynda S, Lisa G, Moore DT, Frances C, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res: an official journal of the American Association for Cancer Research. 2017;13(8):2329–34.CrossRef
39.
go back to reference Fong A, Shafiq J, Saunders C, Thompson AM, Tyldesley S, Olivotto IA, et al. A comparison of surgical and radiotherapy breast cancer therapy utilization in canada (british columbia), scotland (dundee), and australia (western australia) with models of “optimal” therapy. The Breast. 2012;21(4):570–7.CrossRef Fong A, Shafiq J, Saunders C, Thompson AM, Tyldesley S, Olivotto IA, et al. A comparison of surgical and radiotherapy breast cancer therapy utilization in canada (british columbia), scotland (dundee), and australia (western australia) with models of “optimal” therapy. The Breast. 2012;21(4):570–7.CrossRef
40.
go back to reference Liu J, Hunter S, Zhu J, Lee RLT, Chan SW. Decision-making experience related to mastectomy among women with breast cancer: an integrative review. Cancer Nurs. 2021;44(6):E670–86.CrossRef Liu J, Hunter S, Zhu J, Lee RLT, Chan SW. Decision-making experience related to mastectomy among women with breast cancer: an integrative review. Cancer Nurs. 2021;44(6):E670–86.CrossRef
Metadata
Title
Predictors of surgery choices in women with early-stage breast cancer in China: a retrospective study
Authors
Sijia Huang
Qingmo Yang
Xujuan Zheng
Ka Ming Chow
Junhua Wu
Jiemin Zhu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-10510-4

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine